Drug product
Clonidine Transdermal System, USP 0.1 mg/day, 4 patches per carton, Rx only, Manufactured by: Actavis Laboratories, UT Inc., Salt Lake City, UT, Distributed by: Actavis Pharma, Inc., Parsippany, NJ NDC 0591-3508-04
D-0235-2022
Product summary
- Event
- Event 88938
- Status
- Terminated
- Classification
- Class III
- Quantity
- 64,978 patches
- Official record key
drug-enforcement:D-0235-2022
Official wording
Reason: Failed Impurities/Degradation Specifications
Code information: Lot# 1369117B, exp. date 11/2021
Distribution pattern: Nationwide and Puerto Rico
Derived failure modes
-
Potency or specification failure
Failed Impurities/Degradation Specifications